Tessa Therapeutics Appoints Mr. Desmond Lim as Chief Financial Officer
SINGAPORE, Dec. 12, 2017 /PRNewswire/ — Tessa Therapeutics, a clinical stage biopharmaceutical company focusing on cellular immunotherapy treatments for solid tumors, today announces the appointment of Mr. Desmond Lim as Chief Financial Officer.
Mr. Lim has over 25 years of finan…